Q4340 Simpligraft HCPCS Reimbursement & Policy

HCPCS Level II code Q4340 designates Simpligraft billed per square centimeter as an add-on item reported in addition to a primary grafting or wound repair procedure. As an HCPCS Level II add-on code, it captures use of a proprietary skin substitute product used in clinical settings for soft-tissue repair and wound management. Nationally, accurate reporting of add-on HCPCS codes like Q4340 matters for documenting device utilization, clinical outcomes, and proper payment for adjunctive graft materials.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The review covers typical payer coverage considerations, coding and billing scenarios where Q4340 is applied, and common modifier practices observed in billed claims.

Readers will gain a concise understanding of the clinical context for Simpligraft use, typical sites of service where the product is applied, and the administrative elements that affect coding and reimbursement. The publication also summarizes available benchmarks and policy updates relevant to HCPCS add-on reporting, and outlines practical documentation points that support correct use of Q4340. Data not available in the input is noted where applicable.

Billing Code Overview

HCPCS Level II code Q4340 represents Simpligraft, billed per square centimeter. This is an add-on product intended to be reported separately in addition to a primary procedure when used as part of a wound repair or grafting service.

Service Type: Advanced wound graft/skin substitute application

Typical Site of Service: Hospital outpatient department, ambulatory surgical center, or other procedural settings where surgical grafting is performed

Data not available in the input.

Clinical Context

A 58-year-old patient with a full-thickness cutaneous defect of the lower leg following excision of a chronic nonhealing wound presents to an outpatient surgical center for reconstruction. After sharp debridement and preparation of the wound bed under local sedation or regional block, the surgical team elects to apply a dermal substitute product billed as Q4340 (Simpligraft) on a per square centimeter basis as an add-on to the primary wound reconstruction procedure. The clinical workflow includes preoperative wound assessment, measurement of defect surface area to calculate product units, sterile preparation, application of the Simpligraft scaffold to the defect, fixation with sutures or staples as indicated, placement of appropriate dressing, and postoperative instructions with scheduled wound care follow-up. Typical sites of service include hospital outpatient departments, ambulatory surgery centers, and inpatient operating rooms when performed in conjunction with major debridement or reconstruction. The typical patient scenario involves patients with chronic ulcers, traumatic soft-tissue loss, or post-excisional defects who require a dermal matrix in addition to the primary procedure to support tissue regeneration and eventual skin grafting or secondary closure.

Coding Specifications

Modifier	Description	When to Use
`00`	Default / Unspecified	Use when no other modifier applies and insurer requires an explicit default modifier.

Taxonomy Code	Specialty	Notes
`207L00000X`	Orthopaedic Surgery	Frequently involved for complex traumatic soft-tissue defects of extremities.
`207P00000X`	Dermatology	Commonly performs excisions and dermal matrix placement for skin defects and ulcers.
`208000000X`	General Surgery	Manages complex wound debridement and reconstruction across body sites.
`363A00000X`	Podiatry	Applies dermal substitutes for foot and ankle ulcers and diabetic wounds.
`2086S0125X`	Plastic and Reconstructive Surgery	Regularly performs dermal substitute application for reconstruction and coverage.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`L97.423`	Non-pressure chronic ulcer of left calf with fat layer exposed	Chronic lower extremity ulcers often require debridement and dermal matrix placement to promote healing.
`L97.324`	Non-pressure chronic ulcer of left ankle with muscle exposed	Deeper ulcers with exposed muscle may need dermal substitutes as part of staged reconstruction.
`S81.811A`	Laceration without foreign body of right lower leg, initial encounter	Traumatic soft-tissue loss from lacerations may be reconstructed with Simpligraft to support closure.
`C44.91`	Malignant neoplasm of skin of unspecified part of face, unspecified — placeholder for post-excisional defects	Post-excisional defects after skin cancer removal sometimes require dermal matrix adjuncts.
`E11.621`	Type 2 diabetes mellitus with foot ulcer	Diabetic foot ulcers commonly receive adjunctive dermal substitutes to aid healing and prevent amputation.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11042`	Debridement, subcutaneous tissue (e.g., open wounds), first 20 sq cm or less	Commonly performed immediately before Simpligraft placement to prepare wound bed.
`11043`	Debridement, muscle and fascia, first 20 sq cm or less	Used when deeper debridement is required prior to dermal matrix application.
`15271`	Application of skin substitute graft to trunk, arms, legs; first 100 sq cm or less, or single application	May be performed in conjunction with Simpligraft as part of staged reconstruction and coverage.
`15732`	Muscle, myocutaneous, or fasciocutaneous flap with microvascular anastomosis	Complex reconstructive option used when dermal substitute alone is insufficient; may be part of combined workflow.
`15002`	Full-thickness graft, head/neck; first 20 sq cm or less, or single-digit finger	Skin grafting performed after dermal matrix integration as definitive coverage.

OpenPayer

Summary & Overview

HCPCS Level II Q4340: Simpligraft per Square Centimeter